Nuvation Bio Inc., a clinical-stage biopharmaceutical company, focuses on developing product candidates for cancer treatment. The company's lead product candidate is IBTROZI (taletrectinib), a ROS1 inhibitor for the treatment of patients wi...
Leadership
David T. Hung M.D.Founder
Founder, President, CEO & Chairman
Philippe Pierre Sauvage
CFO & Principal Financial Officer
Gary Hattersley Ph.D.
Chief Scientific Officer
Moses Makunje CPA
VP of Finance and Principal Accounting & Financial Officer
David C. Hanley Ph.D.
Chief Technical Operations Officer
Robert DeVita
Vice President of Corporate Development & Investor Relations
